Hologic Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Hologic yıllık ortalama 5.4% oranında kazançlarını artırırken, Medical Equipment sektöründe kazançlar growing at 13.3% annual. Gelirler growing yılda ortalama 2.9% oranında artmaktadır. Hologic'in özkaynak karlılığı 14.2% ve net marjı 17.6%'dir.

Anahtar bilgiler

5.4%

Kazanç büyüme oranı

6.5%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi8.9%
Gelir büyüme oranı2.9%
Özkaynak getirisi14.2%
Net Marj17.6%
Son Kazanç Güncellemesi29 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

When Should You Buy Hologic, Inc. (NASDAQ:HOLX)?

Nov 02
When Should You Buy Hologic, Inc. (NASDAQ:HOLX)?

Hologic: Continued Room Amidst Bolt-On M&A Efforts

Oct 28

Hologic (NASDAQ:HOLX) Seems To Use Debt Rather Sparingly

Oct 17
Hologic (NASDAQ:HOLX) Seems To Use Debt Rather Sparingly

Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward

Sep 16
Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward

Hologic, Inc. (NASDAQ:HOLX) Not Flying Under The Radar

Sep 01
Hologic, Inc. (NASDAQ:HOLX) Not Flying Under The Radar

Hologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among Them

Aug 27

Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?

Jul 21
Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?

These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well

Jun 20
These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well

Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down

May 22
Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down

Hologic: Women's Health Play Looks Healthier Itself

May 13

Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult

Apr 19
Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult

Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)

Apr 05
Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet

Mar 20
Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet

Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Feb 22
Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Hologic: Prospects For Growth As Headwinds Disappear

Feb 11

We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings

Feb 09
We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings

Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next

Feb 06
Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next

We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)

Jan 29
We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)

The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)

Dec 30
The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)

Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?

Dec 11
Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Nov 08
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?

Oct 25
Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?

Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement

Sep 28
Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement

Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price

Aug 29
Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Jul 31
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Jul 18
Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing

Jun 21
Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing

Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

May 22
Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Apr 25
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?

Apr 10
What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?

Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher

Mar 13
Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher

Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

Feb 14
Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Jan 18
Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Gelir ve Gider Dağılımı

Hologic nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NasdaqGS:HOLX Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
29 Jun 243,988702985278
30 Mar 243,961467985287
30 Dec 233,969515984286
30 Sep 234,030456995294
01 Jul 234,0384841,012297
01 Apr 234,0577531,016290
31 Dec 224,4669901,045285
24 Sep 224,8631,3021,038283
25 Jun 225,2261,5121,076284
26 Mar 225,3921,5521,092288
25 Dec 215,4941,7161,040290
25 Sep 215,6321,872994276
26 Jun 215,6632,038921257
27 Mar 215,3171,907870243
26 Dec 204,5361,384827221
26 Sep 203,7761,115840223
27 Jun 203,295497845226
28 Mar 203,325453859232
28 Dec 193,38784895240
28 Sep 193,367-204897232
29 Jun 193,315-30878225
30 Mar 193,287-11882218
29 Dec 183,258-419883217
29 Sep 183,218-111915219
30 Jun 183,207-79866227
31 Mar 183,189-132853235
30 Dec 173,1161,076838233
30 Sep 173,059756819233
01 Jul 172,983765764235
01 Apr 172,894790721231
31 Dec 162,872332686235
24 Sep 162,833331676232
25 Jun 162,809264671223
26 Mar 162,785208667221
26 Dec 152,747187647215
26 Sep 152,705132624215
27 Jun 152,641135610213
28 Mar 152,580116590210
27 Dec 142,54952587207
27 Sep 142,53117590203
28 Jun 142,477-1,125572200
29 Mar 142,470-1,147568195
28 Dec 132,458-1,181581195

Kaliteli Kazançlar: HOLX yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: HOLX 'nin mevcut net kar marjları (17.6%) geçen yılın (12.1%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: HOLX son 5 yılda karlı hale geldi ve kazançlarını yıllık 5.4% oranında artırdı.

Büyüme Hızlandırma: HOLX 'un son bir yıldaki kazanç büyümesi ( 43.2% ) 5 yıllık ortalamasını (yıllık 5.4% ) aşıyor.

Kazançlar vs. Sektör: HOLX geçen yılki kazanç büyümesi ( 43.2% ) Medical Equipment sektörünün 12.2% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: HOLX 'nin Özsermaye Getirisi ( 14.2% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin